BSEGeneral8 Sept 2026 · 8 Sept 2026, 08:35 pm

Annual Report of the Company for FY 2025-26.

Orchid Pharma Ltd · 524372

✦ AI SummaryResults

Orchid Pharma Ltd has announced its Annual Report for FY 2025-26, along with the Notice of 33rd Annual General Meeting scheduled for September 29, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Orchid Pharma Ltd - 524372 - Reg. 34 (1) Annual Report.

Attachments (1)

📄

9173803d-c576-421f-8c50-d8a9d14f5590.pdf

pdf

Download →
View document text
OrchidPharm~W -- A Dhanuka Group Company ------------------------------------ September 07, 2026 National Stock Exchange of India Limited, BSE Limited Exchange Plaza, Bandra Kurla Complex, Phiroze Jeejeebhoy Towers, Dalal Bandra (E), Mumbai-400051 Street, Fort, Mumbai- 400001 Symbol: ORCHPHARMA Scrip Code: 524372 Ref.: Regulation 34(1) and 30 read with Para A Part A of Schedule III of Securities and Exchange Board of India (Listing Obligations and Disclosure Reguirements) Regulations, 2015, as amended ("SEBI Listing Regulations") Sub: Annual Report and Notice of 33rd Annual General Meeting of Orchid Pharma Limited ("the Company") for the F.Y. 2025-26 Dear Sir/Madam, This is in continuation to our earlier intimation dated September 03, 2026 stating the information regarding the 33rd Annual General Meeting of the Company for the Financial Year ended on March 31, 2026. With reference to the captioned subject and pursuant to Regulation 30 read with Para A Part A of Schedule III of SEBI Listing Regulations, please find enclosed herewith the Annual Report of the Company for the F.Y.2025-26, inter- alia including the Notice of 33rd Annual General Meeting of the Company, scheduled to be held on Tuesday, September 29,2026 at 12.00 Noon (1ST) through Video Conferencing / Other Audio Visual Means ("VC" / "OAVM"), forming part of the said Annual Report. The same had been sent via email to the members of the Company as on the cut-off date i.e. September 04, 2026, whose email address is registered with the Registrar and Transfer Agent of the Company / Depository Participants and letters have been dispatched to the members who have not so registered the email-id, providing the web-link, including the exact path, where complete details of the Annual Report is available. The said Annual Report and Notice of 33rd Annual General Meeting are also available on the website of the Company at https:/Iorchid-pharma.b cd n. net/pdf/An nua I % 20Report%202025-26. pdf You are requested to take above information on record. Thanking You, For Orchid Pharma Limited Kapil Dayya Company Secretary & Compliance Officer M. No.: Fl0698 Encl.: as above +91-44-27444471/72/73 corporate@orchidpharma.com orchidpharma.com CIN: L24222TN1992PLC022994 Registered Office: Corporate Office: Orchid Pharma Limited 15th Floor, Tower 1, DLF Corporate Greens, Sector 74A, Plot Nos. 121-128, 128A-133, 138-151,159-164, SIDCO Industrial Estate, Gurugram - 122004, Haryana, India Alathur, Chengalpattu Dist - 603110, Tamil Nadu, India.